Salimetrics Europe appoints Dr Agnes Ernst to join its commercial team
The continued expansion of the Salimetrics salivary bioscience business within Europe has led to the appointment of Dr Agnes Ernst, who joins the company in the UK.
Agnes originates from Austria and studied Medical and Pharmaceutical Biotechnology at the University of Applied Sciences in Krems, Austria. Part of her four year study programme involved carrying out an eight month internship in the Bahn lab at the CCNR using immunological and mass spectrometry profiling methods to identify and characterize biomarkers for schizophrenia.
After her graduation in June 2008, Agnes recommenced her work in the Bahn Lab as a PhD student , studying the complex interplay of metabolic disturbances in schizophrenia and other neuropsychiatric diseases. This project will also attempt to identify biomarkers related to these pathways for use in monitoring the effectiveness of established and novel therapeutic treatment strategies.
Agnes is fluent in German (native) and can speak French and Spanish. She therefore brings with her a full range of skills in order to join Salimetrrics' dedicated team in the UK, where her knowledge of Biotechnology, Neuroscience and Biochemistry will be invaluable.
To read more information, click here.
Salimetrics, founded over 15 years ago by Professor Douglas Granger, Penn State University USA, develops and markets Salivary Assay Kits and Saliva Testing Services for the non invasive measurement of Biomarkers such as Cortisol as an alternative to blood and urine for both research and diagnostic use. The EU Affiliate Salimetrics Europe opened its offices, distribution centre and testing facilities within the UK during 2008 and mirrors all services offered by the US Company